Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission – experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG)
暂无分享，去创建一个
H. Döhner | G. Fingerle-Rowson | M. Hallek | S. Stilgenbauer | B. Emmerich | C. Wendtner | M. Kneba | M. Ritgen | H. Diem | C. Schweighofer | H. Campe | R. Busch | B. Eichhorst | G. Jäger | A. Engert | the German Hodgkin Study Group